Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Branched chain amino acids (BCAAs) industry 3600 synopsis, 2018 – 2032
2.2 Business trends
2.3 Type trends
2.4 Form trends
2.5 Application trends
2.6 Regional trends
Chapter 3 Branched chain amino acids (BCAAs) Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.2 Industry pitfalls & challenges
3.3 Growth potential analysis
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Pricing analysis, 2022
3.7 Technology landscape
3.7.1 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Russia-Ukraine War Impact on the industry
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Branched chain amino acids (BCAAs) Market Size and Forecast, By Type 2018 - 2032
5.1 Branched chain amino acids (BCAAs) Market Trends, By type
5.2 L-Leucine
5.3 L-Isoleucine
5.4 L-Valine
Chapter 6 Branched chain amino acids (BCAAs) Market Size and Forecast, By Application 2018 - 2032
6.1 Branched chain amino acids (BCAAs) Market Trends, By application
6.2 Sports nutrition and fitness
6.3 Food and beverage
6.4 Animal feed
6.5 Pharmaceuticals
6.6 Cosmetics and personal care
Chapter 7 Branched chain amino acids (BCAAs) Market Size and Forecast, By Form 2018 - 2032
7.1 Branched chain amino acids (BCAAs) Market Trends, By form
7.2 Powder
7.3 Capsule
7.4 Tablet
7.5 Liquid
Chapter 8 Branched chain amino acids (BCAAs) Market Size and Forecast, By Region 2018 - 2032
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Malaysia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
Chapter 9 Company Profiles
9.1 Ajinomoto
9.2 Kyowa Hakko Bio
9.3 Evonik
9.4 BASF
9.5 Toray Industries
9.6 DSM
9.7 Kerry Group
9.8 Glanbia
9.9 Archer Daniels Midland (ADM)
9.10 Cargill
9.11 Tate & Lyle
9.12 Glanbia Nutritionals
9.13 NOW Foods
9.14 Optimum Nutrition
9.15 MuscleTech
